Reuters logo
BRIEF-AcelRx Pharmaceuticals reports Q1 total revenue $3.1 million
May 8, 2017 / 8:22 PM / 7 months ago

BRIEF-AcelRx Pharmaceuticals reports Q1 total revenue $3.1 million

May 8 (Reuters) - AcelRx Pharmaceuticals Inc

* AcelRx Pharmaceuticals reports first quarter 2017 financial results and provides corporate update

* Q1 loss per share $0.34

* Q1 earnings per share view $-0.27 -- Thomson Reuters I/B/E/S

* AcelRx Pharmaceuticals - As of March 31, AcelRx had cash, cash equivalents and investments of $72.3 million, compared to $80.3 million at December 31, 2016

* Q1 total revenue $3.1 million versus $3.0 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below